CEACAM1/CD66a Antibody (F7) - BSA Free
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-59673
Conjugate
Catalog #
Key Product Details
Species Reactivity
Rat
Applications
ELISA, Flow Cytometry, Immunohistochemistry, Immunoprecipitation, Western Blot
Label
Unconjugated
Antibody Source
Monoclonal Mouse IgG1 kappa Clone # F7
Format
BSA Free
Concentration
1 mg/ml
Product Specifications
Immunogen
The immunogen for this antibody is proprietary.
Specificity
Binds specific to the N-domain of rat CEACAM1. Does not cross-react with human CEACAM-1, -3. -4, -5, -6, 7 and -8, mouse CEACAM1 and mouse CEACAM2.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1 kappa
Scientific Data Images for CEACAM1/CD66a Antibody (F7) - BSA Free
Flow Cytometry: CEACAM1/CD66a Antibody (F7) - BSA Free [NBP2-59673]
Flow Cytometry: CEACAM1/CD66a Antibody (F7) [NBP2-59673] - mAb F7 Mouse anti rat CEACAM1 IgG1 kappaApplications for CEACAM1/CD66a Antibody (F7) - BSA Free
Application
Recommended Usage
ELISA
1:100 - 1:2000
Flow Cytometry
1:10 - 1:1000
Immunohistochemistry
1:10 - 1:500
Immunoprecipitation
1:10 - 1:500
Western Blot
1:100 - 1:2000
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
PBS
Format
BSA Free
Preservative
0.02% Sodium Azide
Concentration
1 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: CEACAM-1/CD66a
Long Name
Carcinoembryonic Antigen-related Cell Adhesion Molecule 1
Alternate Names
BGP1, Biliary Glycoprotein 1, CD66a, Cea-1, CEACAM1, Hv-1, Hv-2, MHVR
Gene Symbol
CEACAM1
Additional CEACAM-1/CD66a Products
Product Documents for CEACAM1/CD66a Antibody (F7) - BSA Free
Product Specific Notices for CEACAM1/CD66a Antibody (F7) - BSA Free
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...